专利检索 ap:("Institut Curie" OR "Centre national de la recherche scientifique" OR "Institut National de la Santé et de la Recherche Médicale (INSERM)" OR "Commissariat à l'Énergie Atomique et aux Énergies Alternatives" OR "Assistance Publique-Hôpitaux de Paris (APHP)" OR "Université de Paris" OR "University of Utah Research Foundation") AND inv:"SCHMIDT, Frédéric" 第 1 页

1.

发明公开
METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STXB) MONOMERS AND OLIGOMERS, AND USES THEREOF 审中-公开

公开(公告)号：EP3980057A1

公开(公告)日：2022-04-13

申请号：EP20729116.2

申请日：2020-06-04

申请人： Institut Curie , Centre national de la recherche scientifique , Institut National de la Santé et de la Recherche Médicale (INSERM) , Commissariat à l'Énergie Atomique et aux Énergies Alternatives , Assistance Publique-Hôpitaux de Paris (APHP) , Université de Paris , University of Utah Research Foundation

发明人： BILLET, Anne , SCHMIDT, Frédéric , JOHANNES, Ludger , SERVENT, Denis , MOURIER, Gilles , TARTOUR, Éric , KAY, Michael , FULCHER, James M.

IPC分类号： A61K39/112 , C07K14/25

2.

发明公开
DERIVATIVES OF ETOPOSIDE AND ANALOGS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM 审中-公开
标题翻译： ETIPOSIDDERIVATE及其类似物，并含有药物组合物

公开(公告)号：EP1438319A1

公开(公告)日：2004-07-21

申请号：EP02781289.0

申请日：2002-10-25

申请人： CENTRE NATIONAL DELA RECHERCHE SCIENTIFIQUE (CNRS) , Institut Curie

发明人： MONNERET, Claude , SCHMIDT, Frédéric

IPC分类号： C07H17/04 , C07H15/203 , C07H7/033 , A61K31/7048 , A61P35/00

CPC分类号： C07H15/203 , C07H7/033 , C07H17/04 , Y02P20/55

摘要： The invention relates to compounds having the following formula (I), in which: Ra represents a sugar moiety, an arylamino group, or an alkyl group comprising at least one amino group, Rb represents an halogen atom, an halogenoalkyl group, a nitro group, or a group -NR(COR') in which R and R', independently from each other, represent an alkyl group, R1 represents H, or a protecting group for COOH group, R2, R3, and R4, independently from each other, represent H, or a protecting group for OH group. The invention also relates to the use of such compounds in pharmaceutical compositions for the treatment of cancers.